Alpha 2.0
Login Register
» Authors » Cesar Pedroza-Roldan

Cesar Pedroza-Roldan

Explore the profile of Cesar Pedroza-Roldan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 135
Followers 0
Related Specialties
Allergy & Immunology
Microbiology
Infectious Diseases
Top 10 Co-Authors
Mario Alberto Flores-Valdez
Michel de Jesus Aceves-Sanchez
Claudia Charles-Nino
Rogelio Hernandez-Pando
Cristian Alfredo Segura-Cerda
Dulce Mata-Espinosa
Helle Bielefeldt-Ohmann
Abel Gutierrez-Ortega
Jorge Barrios-Payan
Brenda Marquina-Castillo
Published In
Vaccine
Tuberculosis (Edinb)
Mol Immunol
Microb Drug Resist
IUBMB Life
Affiliations
Soon will be listed here.
Recent Articles
1.
A second-generation recombinant BCG strain combines protection against murine tuberculosis with an enhanced safety profile in immunocompromised hosts
Valencia-Hernandez A, Zhao G, Miranda-Hernandez S, Segura-Cerda C, Pedroza-Roldan C, Seifert J, et al.
Vaccine . 2024 Sep; 42(24):126291. PMID: 39241355
Bacille Calmette-Guérin (BCG) remains the only licensed vaccine against tuberculosis (TB). While BCG protects against TB in children, its protection against pulmonary TB in adults is suboptimal, and the development...
2.
Erratum to "BCGΔBCG1419c and BCG differ in induction of autophagy, c-di-GMP content, proteome, and progression of lung pathology in Mycobacterium tuberculosis HN878-infected male BALB/c mice" [Vaccine 41(26) (2023) 3824-3835]
Aceves-Sanchez M, Barrios-Payan J, Segura-Cerda C, Flores-Valdez M, Mata-Espinosa D, Pedroza-Roldan C, et al.
Vaccine . 2024 Feb; 42(7):1852-1853. PMID: 38360477
No abstract available.
3.
Proteome and immunogenicity differences in BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c during planktonic growth in 7H9 and Proskauer Beck media
Flores-Valdez M, Velazquez-Fernandez J, Pedroza-Roldan C, Aceves-Sanchez M, Gutierrez-Ortega A, Lopez-Romero W, et al.
Tuberculosis (Edinb) . 2023 Dec; 144:102432. PMID: 38041962
Bacillus Calmette-Guèrin (BCG) remains as the only vaccine employed to prevent tuberculosis (TB) during childhood. Among factors likely contributing to the variable efficacy of BCG is the modification in its...
4.
BCG∆BCG1419c and BCG differ in induction of autophagy, c-di-GMP content, proteome, and progression of lung pathology in Mycobacterium tuberculosis HN878-infected male BALB/c mice
Aceves-Sanchez M, Barrios-Payan J, Segura-Cerda C, Flores-Valdez M, Mata-Espinosa D, Pedroza-Roldan C, et al.
Vaccine . 2023 May; 41(26):3824-3835. PMID: 37164819
The efficacy of BCG vaccines against Mycobacterium tuberculosis (Mtb) strains of lineage 2 (Beijing) in preclinical models and humans has been questioned. We have developed BCG∆BCG1419c, by deletion of BCG1419c...
5.
Exclusive circulation of canine parvovirus type 2c in the Guadalajara metropolitan area in western Mexico: a five-year study
Pedroza-Roldan C, Hernandez-Almaraz M, Elizondo-Quiroga D, Gutierrez-Ortega A, Acosta-Monroy C, Charles-Nino C, et al.
Arch Virol . 2022 Jul; 167(11):2109-2121. PMID: 35794491
Canine parvovirus type 2 (CPV-2) infection in dogs is associated with severe gastroenteritis, bloody diarrhea, and vomiting, resulting in high rates of death, especially in unvaccinated puppies within the first...
6.
Prevalence of Measured by Western Blot, ELISA and DNA Analysis, by PCR, in Cats of Western Mexico
Galvan-Ramirez M, Charles-Nino C, Pedroza-Roldan C, Salazar-Reveles C, Ocampo-Figueroa K, Rodriguez-Perez L, et al.
Pathogens . 2022 Jan; 11(1). PMID: 35056057
is the causative agent of toxoplasmosis in humans and animals. The sexual reproductive cycle of takes place in the small intestine of felines, the definitive hosts. In the final part...
7.
Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
Aceves-Sanchez M, Flores-Valdez M, Pedroza-Roldan C, Creissen E, Izzo L, Silva-Angulo F, et al.
Sci Rep . 2021 Jun; 11(1):12417. PMID: 34127755
A single intradermal vaccination with an antibiotic-less version of BCGΔBCG1419c given to guinea pigs conferred a significant improvement in outcome following a low dose aerosol exposure to M. tuberculosis compared...
8.
BCG constitutively expressing the adenylyl cyclase encoded by Rv2212 increases its immunogenicity and reduces replication of M. tuberculosis in lungs of BALB/c mice
Pedroza-Roldan C, Marquina-Castillo B, Mata-Espinosa D, Barrios-Payan J, Aceves-Sanchez M, Hernandez Pando R, et al.
Tuberculosis (Edinb) . 2018 Dec; 113:19-25. PMID: 30514503
Mycobacterium tuberculosis remains as a threat to public health around the world with 1.7 million cases of TB-associated deaths during 2016. Despite the use of Bacillus Calmette-Guerin (BCG) vaccine, control...
9.
The BCGΔBCG1419c Vaccine Candidate Reduces Lung Pathology, IL-6, TNF-α, and IL-10 During Chronic TB Infection
Flores-Valdez M, Pedroza-Roldan C, Aceves-Sanchez M, Peterson E, Baliga N, Hernandez-Pando R, et al.
Front Microbiol . 2018 Jun; 9:1281. PMID: 29946316
(), the causative agent of human tuberculosis (TB), is estimated to be harbored by up to 2 billion people in a latent TB infection (LTBI) state. The only TB vaccine...
10.
Recent mouse models and vaccine candidates for preventing chronic/latent tuberculosis infection and its reactivation
Pedroza-Roldan C, Flores-Valdez M
Pathog Dis . 2018 Apr; 75(6). PMID: 29659820
Tuberculosis (TB) remains a major challenge in public health worldwide. Until today, the only widely used and approved vaccine is the Mycobacterium bovis bacille Calmette-Guerin (BCG). This vaccine provides a...